H. Y. Yang, W. Fratta, E. A. Majane, C. , and E. , , 1985.

, Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine, Proc. Natl. Acad. Sci. U. S. A, vol.82, pp.7757-7761

S. J. Perry, Y. Huang, E. Cronk, D. Bagust, J. Sharma et al., A human gene encoding morphine modulating peptides related to NPFF and FMRFamide, FEBS Lett, vol.409, pp.426-430, 1997.

J. A. Bonini, K. A. Jones, N. Adham, C. Forray, R. Artymyshyn et al., Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF, J. Biol. Chem, vol.275, pp.39324-39331, 2000.

R. Quillet, S. Ayachi, F. Bihel, K. Elhabazi, B. Ilien et al., RF-amide neuropeptides and their receptors in Mammals: Pharmacological properties, drug development and main physiological functions, Pharmacol. Ther, vol.160, pp.84-132, 2016.

C. Gouarderes, I. Quelven, C. Mollereau, H. Mazarguil, S. Q. Rice et al., Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [125I]EYF as selective radioligands, Neuroscience, vol.115, pp.349-361, 2002.

T. Murase, H. Arima, K. Kondo, and Y. Oiso, , 1996.

, Neuropeptide FF reduces food intake in rats, Peptides, vol.17, pp.353-354

M. A. Cline and D. S. Mathews, Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands, Gen. Comp. Endocrinol, vol.159, pp.125-129, 2008.

L. Maletínska, A. Ticha, V. Nagelova, A. Spolcova, M. Blechova et al., Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration, Brain Res, pp.33-40, 1498.

M. Kavaliers and D. D. Colwell, Neuropeptide FF (FLQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice, Neurosci. Lett, vol.157, pp.75-78, 1993.

L. Le?a?d, A. Kova?s, T. Ollmann, L. Pe?zely, O. Zagoracz et al., Positive reinforcing effects of RFamide-related peptide-1 in the rat central nucleus of amygdala, Behav. Brain Res, vol.275, pp.101-106, 2014.

A. Kova?s, K. La?zlo, O. Zagoracz, T. Ollmann, L. Pe?zely et al., Effects of RFamide-related peptide-1 (RFRP-1) microinjections into the central nucleus of amygdala on passive avoidance learning in rats, Neuropeptides, vol.62, pp.81-86, 2017.

M. Allard, S. Labrouche, A. Nosjean, and R. Laguzzi, Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat, J. Pharmacol. Exp. Ther, vol.407, pp.245-255, 1995.

H. Arima, T. Murase, K. Kondo, Y. Iwasaki, and Y. Oiso, Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats, Endocrinology, vol.137, pp.1523-1529, 1996.

S. Ayachi and S. , Involvement of Mammalian RF-Amide Peptides and Their Receptors in the Modulation of Nociception in Rodents, Front. Endocrinol, vol.5, p.158, 2014.

R. B. Rothman, A review of the role of anti-opioid peptides in morphine tolerance and dependence, Synapse, vol.12, pp.129-138, 1992.

R. Melzack, The stragedy of needless pain, Sci. Am, vol.262, issue.2, pp.27-33, 1990.

E. Collin, P. Poulain, A. Gauvain--piquard, G. Petit, E. Pichard-leandri et al., Pain facilitatory circuits in the mammalian central nervous system: their behavioral significance and role in morphine analgesic tolerance, Neurosci. Biobehav. Rev, vol.55, issue.18, pp.1059-1078, 1993.

E. Ce?erier, C. Rivat, Y. Jun, J. Laulin, A. Larcher et al., Long-lasting Hyperalgesia Induced by Fentanyl in Rats: Preventive Effect of Ketamine, Anesthesiology, vol.92, pp.465-472, 2000.

L. A. Colvin, M. T. Fallon, M. S. Angst, and J. D. Clark, Opioid-induced Hyperalgesia: A Qualitative Systematic Review, 125?127. (21), vol.104, pp.570-587, 2006.

F. Simonin, M. Schmitt, J. Laulin, E. Laboureyras, J. H. Jhamandas et al., RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.466-471, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00188146

J. Lameh, F. Bertozzi, N. Kelly, P. M. Jacobi, D. Nguyen et al., , 2010.

F. F. Neuropeptide and . Receptors, Have Opposing Modulatory Effects on Nociception, J. Pharmacol. Exp. Ther, vol.334, pp.244-254

K. Elhabazi, J. Trigo, C. Mollereau, L. Mouledous, J. Zajac et al., ACS Chemical Neuroscience Research Article

, ACS Chem. Neurosci, vol.9, pp.2599-2609, 2018.

B. Bockel, F. Maldonado, R. Simonin, and F. , Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments: NPFF receptors in neuroadaptive responses to opiates, Br. J. Pharmacol, vol.165, pp.424-435, 2012.

F. Bihel, J. Humbert, S. Schneider, I. Bertin, P. Wagner et al., Development of a Peptidomimetic Antagonist of Neuropeptide FF Receptors for the Prevention of Opioid-Induced Hyperalgesia, ACS Chem. Neurosci, vol.6, pp.438-445, 2015.

R. Gealageas, S. Schneider, J. Humbert, I. Bertin, M. Schmitt et al., Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors, Bioorg. Med. Chem. Lett, vol.22, pp.7471-7474, 2012.

V. B. Journigan, C. Me?angeau, N. Vyas, S. O. Eans, S. J. Cutler et al., Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors, J. Med. Chem, vol.57, pp.8903-8927, 2014.

J. V. Mankus and C. R. Mccurdy, Nonpeptide ligands of neuropeptide FF: current status and structural insights, Future Med. Chem, vol.4, pp.1085-1092, 2012.

G. Gaubert, F. Bertozzi, N. M. Kelly, J. Pawlas, A. L. Scully et al., Discovery of Selective Nonpeptidergic Neuropeptide FF2 Receptor Agonists, J. Med. Chem, vol.52, pp.6511-6514, 2009.

D. H. Malin, M. M. Henceroth, J. J. Izygon, D. M. Nghiem, W. D. Moon et al., Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions, Neurosci. Lett, vol.584, pp.141-145, 2015.

W. Zhan, Z. Liang, A. Zhu, S. Kurtkaya, H. Shim et al., Discovery of Small Molecule CXCR4 Antagonists, J. Med. Chem, vol.50, pp.5655-5664, 2007.

A. Plumitallo, M. C. Cardia, S. Distinto, A. Delogu, E. Maccioni et al., The Reactions of Hydroiodide of 2-Amino-1-substituted Guanidine Derivatives with Aromatic Isothiocyanates, Heterocycles, vol.59, pp.1135-1142, 2002.

P. H. Nguyen, H. Hammoud, S. Halliez, Y. Pang, J. Evrard et al., Structure?Activity Relationship Study around Guanabenz Identifies Two Derivatives Retaining Antiprion Activity but Having Lost ?2-Adrenergic Receptor Agonistic Activity, ACS Chem. Neurosci, vol.5, pp.1075-1082, 2014.

H. Kuehmstedt, L. Heinisch, I. Wunderlich, and A. Hagen, Synthesis of substituted quinoline aldehyde amidinohydrazones, Pharmazie, vol.12, 1987.

L. Vio and M. G. Mamolo, Potential antihypertensive agents. IV. Aminoguanidine and hydrazinopyrimidine derivatives. IL Farm, vol.38, pp.255-264, 2004.

J. Schroder, A. Henke, H. Wenzel, H. Brandstetter, H. G. Stammler et al., Structure-Based Design and Synthesis of Potent Matrix Metalloproteinase Inhibitors Derived from a 6 H ?1,3,4-Thiadiazine Scaffold, J. Med. Chem, vol.44, pp.3231-3243, 2001.

T. Pyl, L. Seidl, and H. Beyer, Condensation of oxalamidrazone and N,N?-diaminoguanidine with ?-halo ketones, Chem. Ber, vol.101, pp.29-34, 1968.

S. Baskaran, E. Hanan, D. Byun, and W. Shen, A facile reduction of 2-aminopyrimidines with triethylsilane and trifluoroacetic acid, Tetrahedron Lett, vol.45, pp.2107-2111, 2004.

J. Contreras, Y. M. Rival, S. Chayer, J. Bourguignon, and C. G. Wermuth, Aminopyridazines as Acetylcholinesterase Inhibitors, J. Med. Chem, vol.42, pp.730-741, 1999.

K. L. Billingsley, K. W. Anderson, and S. L. Buchwald, A Highly Active Catalyst for Suzuki?Miyaura Cross-Coupling Reactions of Heteroaryl Compounds, Angew. Chem., Int. Ed, vol.45, pp.3484-3488, 2006.

K. Elhabazi, J. Humbert, I. Bertin, M. Schmitt, F. Bihel et al., Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors, Neuropharmacology, vol.75, pp.164-171, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00860085

V. Joly, P. Richebe, B. Guignard, D. Fletcher, P. Maurette et al., Remifentanil-induced Postoperative Hyperalgesia and Its Prevention with Small-dose Ketamine, Anesthesiology, vol.103, pp.147-155, 2005.

J. O. Diraddo, E. J. Miller, H. A. Hathaway, E. Grajkowska, B. Wroblewska et al., A Real-Time Method for Measuring cAMP Production Modulated by G I/O-Coupled Metabotropic Glutamate Receptors, J. Pharmacol. Exp. Ther, vol.349, issue.3, pp.373-382, 2014.

J. Gilissen, P. Geubelle, N. Dupuis, C. Laschet, B. Pirotte et al., Forskolin-Free cAMP Assay for Gi-Coupled Receptors, Biochem. Pharmacol, vol.98, issue.3, pp.381-391, 2015.

V. Kayser, A. I. Basbaum, and G. Guilbaud, , 1990.

, Deafferentation in the Rat Increases Mechanical Nociceptive Threshold in the Innervated Limbs, Brain Res, vol.508, pp.329-332

K. Elhabazi, S. Ayachi, B. Ilien, and F. Simonin, Assessment of Morphine-Induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities, J. Visualized Exp, vol.89, 2014.

F. Simonin, Disruption of the Kappa -Opioid Receptor Gene in Mice Enhances Sensitivity to Chemical Visceral Pain, Impairs Pharmacological Actions of the Selective Kappa -Agonist U-50,488H and Attenuates Morphine Withdrawal, EMBO J, vol.17, issue.4, pp.886-897, 1998.